An evidence‐based systematic review of the off‐label uses of lisinopril-Reference-Cited by-同舟云学术

An evidence‐based systematic review of the off‐label uses of lisinopril

Published:2018-09-11 Issue:11 Volume:84 Page:2502-2521
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Sadat‐Ebrahimi Seyyed‐Reza¹²³^ORCID,Parnianfard Neda¹²,Vahed Nafiseh¹²,Babaei Hossein³⁴,Ghojazadeh Morteza⁵,Tang Sydney⁶,Azarpazhooh Amir⁷⁸⁹

Affiliation:

1. Research Center for Evidence‐Based Medicine, Health Management and Safety Promotion Research InstituteTabriz University of Medical Sciences Tabriz Iran

2. Iranian EBM Center: A Joanna Briggs Institute Affiliated Group

3. Drug Applied Research CenterTabriz University of Medical Sciences Tabriz Iran

4. Faculty of PharmacologyTabriz University of Medical Sciences Tabriz Iran

5. Research Development & Coordination Center, Faculty of MedicineTabriz University of Medical Sciences Tabriz Iran

6. Division of Nephrology, Department of MedicineUniversity of Hong Kong, Queen Mary Hospital Hong Kong

7. Mount Sinai Hospital, Sinai Health System Toronto Canada

8. Faculty of DentistryUniversity of Toronto Toronto Canada

9. Clinical Epidemiology & Health Care Research, Institute of Health Policy, Management and Evaluation, Faculty of MedicineUniversity of Toronto Toronto Canada

Funder

Iranian Evidence-Based Medicine Center of Excellence, Tabriz University of Medical Sciences, Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13705

Reference67 articles.

1. Frankel D.Office of Technology Assessment. Drug labeling in developing countries. OTA‐H‐464 Washington 1993.

2. WittichCM BurkleCM LanierWL editors.Ten common questions (and their answers) about off‐label drug use. Mayo Clin Proc;2012: Elsevier.

3. Drug, Patient, and Physician Characteristics Associated With Off-label Prescribing in Primary Care